Bionano Genomics Inc. (NASDAQ: BNGO)
$0.3475
+0.0922 ( +12.10% ) 54.6M
At close: Jan 3, 2025, 4:00 PM EDT.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.
Market Data
Open
$0.3475
Previous close
$0.2553
Volume
54.6M
Market cap
$30.65M
Day range
$0.2710 - $0.3740
52 week range
$0.1940 - $1.9000
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
def | Proxies and info statements | 4 | Dec 05, 2024 |
8-k | 8K-related | 13 | Dec 02, 2024 |
pre | Proxies and info statements | 4 | Nov 25, 2024 |
10-q | Quarterly Reports | 74 | Nov 14, 2024 |
8-k | 8K-related | 16 | Nov 13, 2024 |
8-k | 8K-related | 19 | Oct 31, 2024 |
8-k | 8K-related | 16 | Oct 10, 2024 |
4 | Insider transactions | 1 | Oct 02, 2024 |
3 | Insider transactions | 3 | Sep 30, 2024 |
4 | Insider transactions | 1 | Sep 13, 2024 |